ArticleJournal of hepatocellular carcinoma2021

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma.

Zhimei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.